Abstract
With the increasing survival of children with malignancies, the long-term effects of chemotherapies are now becoming important and one of these dreadful long-term complications is the development of a second malignancy. Described here is a case of transitional cell carcinoma of the bladder developing 8 years following exposure to cyclophosphamide for the treatment of embryonal rhabdomyosarcoma.
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols
-
Bone Neoplasms / congenital
-
Bone Neoplasms / drug therapy*
-
Carcinoma, Transitional Cell / chemically induced*
-
Carcinoma, Transitional Cell / diagnostic imaging
-
Carcinoma, Transitional Cell / therapy
-
Combined Modality Therapy
-
Cyclophosphamide / adverse effects*
-
Cyclophosphamide / therapeutic use
-
Cystoscopy / methods
-
Dactinomycin
-
Follow-Up Studies
-
Humans
-
Male
-
Monitoring, Physiologic
-
Radiography
-
Radiotherapy, Adjuvant
-
Rhabdomyosarcoma / congenital
-
Rhabdomyosarcoma / drug therapy*
-
Time Factors
-
Treatment Outcome
-
Urinary Bladder Neoplasms / chemically induced*
-
Urinary Bladder Neoplasms / diagnostic imaging
-
Urinary Bladder Neoplasms / therapy
-
Vincristine
Substances
-
Dactinomycin
-
Vincristine
-
Cyclophosphamide